Skip to search formSkip to main contentSkip to account menu

CGP 31608

Known as: 4-Thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-(aminomethyl)-6-(1-hydroxyethyl)-7-oxo-, (5R-(5alpha,6beta(R*)))-, CGP-31608 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Lactams

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
The pharmacokinetics and tissue penetration of intravenously administered CGP 31608.
The pharmacokinetics of CGP 31608, a new injectable penem antibiotic, were studied following a 1 g intravenous infusion… 
1987
1987
In vitro activity of CGP 31608, a new penem
The in vitro activity of CGP 31608, a semisynthetic penem derivative, was compared with that of Sch 34343, imipenem, cefoxitin… 
1987
1987
In-vitro activity of two new carbapenems FCE 22101 and CGP 31608 in comparison with imipenem.
The minimum inhibitory concentrations (MICs) of two new penems, CGP 31608 and FCE 22101 were evaluated against 993 aerobic Gram… 
1987
1987
Comparative activity of CGP 31608, nafcillin, cefamandole, imipenem, and vancomycin against methicillin-susceptible and methicillin-resistant staphylococci
The activity of CGP 31608 for 53 strains of Staphylococcus aureus and 48 strains of S. epidermidis, both methicillin susceptible… 
1987
1987
Comparative in vitro activity of CGP 31608, a new penem antibiotic
The in vitro activity of a new penem antimicrobial agent, CGP 31608, was compared with those of imipenem, SCH 34343, and several… 
1987
1987
Comparative in vitro activity of the new Penem CGP 31608
The in vitro activity of CGP 31608 was compared with that of imipenem, gentamicin, cefazolin and ceftazidime against 593 clinical… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)